Antithrombin III deficiency in pregnancy

Primary Care Update for Ob/Gyns

Volumn 6, Issue 4, 1999, Pages 111-114

  Swaim, Laurie S ^a   Gilstrap III, Larry C ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ANTITHROMBIN III DEFICIENCY; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; FAMILY HISTORY; FEMALE; GESTATIONAL AGE; HUMAN; PREGNANCY COMPLICATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOEMBOLISM;

EID: 0033015242     PISSN: 1068607X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1068-607X(99)00008-6     Document Type: Article

References (27)

1. American College of Obstetricians and Gynecologists. 1997 Educational Bulletin, Thromboembolism in pregnancy. March 1997; No. 234.
2. Atrash H.K., Rowley D., Houge C.J. Maternal and perinatal mortality. Curr Opin Obstet Gynecol. 4:(1):1992;61-71.
3. Werner M.J. Antithrombin III deficiency, deep venous thrombosis, and oral contraceptive use. J Adol Health. 17:1995;189-192.
4. Cunningham FG, Mac Donald PC, Gant NF, Leveno KL, Gilstrap LC, Hankins GDV, Clark SL. Hematologic disorders. Chap 51 in Williams Obstetrics. 20 Ed. Appleton and Lange. Stamford, CT. pp 1197-8.
5. Schafer A.I. The hypercoagulable states. Ann of Intern Med. 102:1985;814-828.
6. Rogers G.M., Shulman M.A. Congenital thrombotic disorders. Am J Hematol. 21:1986;419-430.
7. Nelson D.M., Stempel L.E., Brandt J.T. Hereditary antithrombin-III deficiency and pregnancy Report of two cases and review of the literature . Obstet Gynecol. 65:(6):1985;848-853.
8. OMIM: Online Mendelian Inheritance in Man, OMIM™. Center for Medical Genetics, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD) 1998. World Wide Web URL: http://www.ncbi.nlm.nih.gov/omim/.
9. Penner J.A. Hypercoagulation and thrombosis. Med Clin N Amer. 64:(4):July 1980;743-758.
10. Brandt P. Observations during the treatment of antithrombin-III deficient women with heparin and antithrombin concentrate during pregnancy, parturition, and abortion. Thromb Res. 22:1981;15-24.
11. Martinelli I., Cattaneo M., Daniela P., Taioli E., Mannucci P.M. Risk factors for deep venous thrombosis of the upper extremities. Ann Intern Med. 126:(9):1997;707-711.
12. Hirsh J. Thrombosis. Am J Cardiol. 75:(6):1995;3B-4B.
13. Halligan A., Bonner J., Sheppard B., Darling M., Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet and Gynecol. 101:June 1994;488-492.
14. Cernica F., Ricci G., Simone R., Malisano M., Alberico S., Guaschino S. Coagulation and fibrinolysis changes in normal pregnancy increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet, Gynecol and Repro Biol. 73:1997;31-36.
15. Weiner C.P., Brandt J. Plasma antithrombin-III activity in normal pregnancy. Obstet Gynecol. 56:(5):November 1980;601-603.
16. Hellgren M., Tengborn L., Abildgaard U. Pregnancy in women with congenital antithrombin-III deficiency experience of treatment with heparin and antithrombin . Gynecol Obstet Invest. 14:1982;127-141.
17. Conard J., Horellou M.H., Van Dreden P., Lecompte T., Samama M. Thrombosis and pregnancy in congenital deficiencies in AT-III, protein C or protein S Study of 78 women . Thromb Haemost. 63:(2):1990;319-320.
18. Neirhoff M.G., Krewson D.P., Haut M., Librizzi R.J. Heparin therapy for congenital antithrombin-III deficiency in pregnancy. Am J Perinatology. 4:(4):July 1993;311-312.
19. Golino A., Crawford E.M., Gathe J.C., Dekmezian R.H. Recurrent small bowel infarction associated with antithrombin deficiency. Am J Gastroenterol. 92:(2):1997;323-325.
20. Sanson B.J., Friederich P.W., Simioni P., Zanardi S., Huisman M.V., Girolami A., Wouter ten Cate J., Prins M.H. The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Throm Haemost. 75:(3):1996;387-388.
21. Preston F.E., Rosendaal F.R., Walker I.D., Briët E., Berntorp E., Conard J., Fontcuberta J., Makris M., Mariani G., Noteboom W., Padinger I., Legnani C., Scharrer I., Schulman S., van der Meer F.J.M. Increased fetal loss in women with heritable thrombophilia. Lancet. 348:October 1996;913-916.
22. Leclerc J. Management of AT3 deficiency during pregnancy without administration of AT3. Thromb Res. 41:1986;567.
23. Lechner K. AT3 concentrates Are they clinically useful? Thrombosis and Hemostasis. 73:(3):1995;340.
24. ACOG 1998 Committee Opinion: Anticoagulant with low-molecular-weight heparin during pregnancy. November 1998; No. 211.
25. Menache D. Antithrombin-III concentrates. Hematol/Oncol Clin North Am. 6:(5):October 1992;1115-1120.
26. Hynson J.M., Katz J.A., Bueff H.U. Epidural hematoma associated with enoxaparin. Anesth Analg. 82:(5):1996;1072-1075.
27. Dulitzki M., Pauzner R., Langevitz P., Pras M., Many A., Schiff E. Low-molecular-weight heparin during pregnancy and delivery Preliminary experience with 41 pregnancies . Obstet Gynecol. 87:1996;380-383.